You're reading the free version. Trader adds the live tape and alerts.
Start tracking
RARE Sale Disclosure
Horn Howard · SEC Form 4 · Filed Jul 6, 2026
Sale
Calculated transaction value
$155.64K
Horn Howard Chief Financial Officer
RARE
Transaction date
Jul 1, 2026
Public filing date
Jul 6, 2026
Filing lag
Filed 5 days later
RARE daily price context
Close on/before transaction
$32.38
Jul 1, 2026
First close after public filing
$35.87
Jul 7, 2026
30-day return after filing
-30.5%
Through Aug 5, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 4,698 shares @ $33.13
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-296128
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$155.64K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. RARE Current | Sale | Jul 1, 2026 | $155.64K |